Back
Compass Therapeutics Stock Price Chart

This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
51
CMPX
Compass Therapeutics
Last Price:
$3.17
Seasonality Move:
8.78%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CMPX is experiencing slight selling pressure.
Compass Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.15 | Buy |
20-day SMA: | 2.95 | Buy |
50-day SMA: | 2.57 | Buy |
200-day SMA: | 2.21 | Buy |
8-day EMA: | 0.7 | Buy |
20-day EMA: | 0.3 | Buy |
50-day EMA: | 0.12 | Buy |
200-day EMA: | 0.03 | Buy |
Compass Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.25 | Buy |
Relative Strength Index (14 RSI): | 62.93 | Buy |
Chaikin Money Flow: | -201810 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.64 - 3.12) | Buy |
Bollinger Bands (100): | (1.84 - 2.72) | Buy |
Compass Therapeutics Technical Analysis
Jul 16 | Jul 17 | Jul 18 | Jul 21 | Jul 22 | Jul 23 | Jul 24 | Jul 25 | Jul 28 | Jul 29 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
16 | 17 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Compass Therapeutics Stock
Is Compass Therapeutics Stock a Buy?
-
Compass Therapeutics share price is 3.17 while CMPX 8-day simple moving average is 3.15, which is a Buy signal.
-
The stock price of CMPX is 3.17 while Compass Therapeutics 20-day SMA is 2.95, which makes it a Buy.
-
Compass Therapeutics 50-day simple moving average is 2.57 while CMPX share price is 3.17, making it a Buy technically.
-
CMPX stock price is 3.17 and Compass Therapeutics 200-day simple moving average is 2.21, creating a Buy signal.
CMPX Technical Analysis vs Fundamental Analysis
Buy
51
Compass Therapeutics (CMPX)
is a Buy
Is Compass Therapeutics a Buy or a Sell?
-
Compass Therapeutics stock is rated a BuyThe current Compass Therapeutics [CMPX] share price is $3.17. The Score for CMPX is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
Compass Therapeutics Stock Info
Market Cap:
438.4M
Price in USD:
3.17
Share Volume:
605.4K
Compass Therapeutics 52-Week Range
52-Week High:
4.08
52-Week Low:
0.87
Buy
51
Compass Therapeutics (CMPX)
is a Buy
Compass Therapeutics Share Price Forecast
-
What is the Compass Therapeutics stock price today?The Compass Therapeutics stock price is 3.17 USD today.
-
Will CMPX stock go up or go down?Compass Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Compass Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Compass Therapeutics is not overvalued.
Is Compass Therapeutics Stock a Buy?
-
Compass Therapeutics share price is 3.17 while CMPX 8-day exponential moving average is 0.70, which is a Buy signal.
-
The stock price of CMPX is 3.17 while Compass Therapeutics 20-day EMA is 0.30, which makes it a Buy.
-
Compass Therapeutics 50-day exponential moving average is 0.12 while CMPX share price is 3.17, making it a Buy technically.
-
CMPX stock price is 3.17 and Compass Therapeutics 200-day simple moving average is 0.03, creating a Buy signal.
Fundamental Analysis of Compass Therapeutics
Is Compass Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.02 per share, an increase next quarter of $0.01 per share, a decrease this year of $0.15 per share, and a decrease next year of $0.03 per share.
Technical Analysis of Compass Therapeutics
Should I short Compass Therapeutics stock?
-
CMPX Moving Average Covergence Divergence (MACD) indicator is 0.25, suggesting Compass Therapeutics is a Buy
-
Compass Therapeutics Relative Strength Index (RSI) is 62.93, which suggest Compass Therapeutics is overbought
-
The Bollinger Bands (25) for Compass Therapeutics is (2.64 - 3.12), which suggest Compass Therapeutics is a Buy
-
The Bollinger Bands (100) for Compass Therapeutics is (1.84 - 2.72), which suggest Compass Therapeutics is a Buy
* Compass Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.